Donate Toggle Menu

The Kidney Cancer Association is pleased to announce a new slate of seven awards supporting innovative kidney cancer research.

Applications are now open for the following awards:

  • KCA Trailblazer Award
    • Six awards, $75,000 each
  • KCA Focus Award – Psychosocial
    • One $75,000 award

“We are excited to offer a range of opportunities to fund research that aligns with our vision to be the universal leader in unlocking the cure for kidney cancer,” said Gretchen E. Vaughan, the KCA’s President and CEO. “Supporting investigators broadly and early is critical in advancing lifesaving care options for patients and families.”

KCA Trailblazer Awards will fund promising young- to mid-career investigators to foster innovative research in kidney cancer. Of note, at least two of the six Trailblazer Awards will be reserved for applicants from institutions that have not received prior KCA research funding.

“Ensuring at least two awards for new-to-us institutions should be a step towards better equity across research and perhaps the chance to help establish new hotbeds of research in this dynamic field,” said Dr. Sumanta Pal, a medical oncologist at City of Hope Comprehensive Cancer Center in Duarte, California and Chair of the KCA’s Grant Committee.

The KCA Focus Awards, which launched in 2021, address acute unmet needs within the kidney cancer community. This year, the KCA will grant one Focus Award – Psychosocial in response to the need from both patients and researchers for a better understanding of the psychosocial issues facing people impacted by kidney cancer including quality of life, supportive and palliative care, pain management, and mental and emotional health. This award is available to healthcare professionals of any kind including oncologists, nurses, social workers, and others in supportive care.

“Both the new KCA Trailblazer Awards and the KCA Focus Award are substantive ways to support the next generation of researchers in kidney cancer; to push the innovation and impact of treatment and care of patients to new heights,” said Dr. Daniel George, a medical oncologist at the Duke Cancer Institute in Durham, North Carolina and Chair of the KCA’s Medical Steering Committee. “This is an extremely exciting time in kidney cancer research when any advance can directly impact our patients’ lives.”

Following the application and selection process, award recipients will be announced in fall 2022. Full details on the grants and application guidelines are available at the application portal.


About the Kidney Cancer Association

The Kidney Cancer Association is a global community dedicated to serving and empowering patients and caregivers, and leading change through advocacy, research, and education in order to be the universal leader in finding the cure for kidney cancer. Founded in 1990 by Eugene P. Schonfeld and a small group of patients and doctors in Chicago, Illinois, the KCA has grown into an international non-profit organization based in Houston, Texas. The KCA promotes scientific advances through two annual research symposiums and a robust grant program, participates in legislative advocacy, and seeks to be a source of education and resources for patients, caregivers, and anyone impacted by kidney cancer.

Media Contact

Radha Chitale
Director of Communications
847.332.1051 ext. 113 | [email protected]